ReSPECT Glioblastoma Clinical Trial Data to be Presented at 2020 Society for Neuro-Oncology Annual MeetingGlobeNewsWire • 10/01/20
Plus Therapeutics Receives Fast Track Designation From FDA for Its Novel Glioblastoma TreatmentGlobeNewsWire • 09/15/20
Plus Therapeutics, Inc. to Present at the 9th Annual Gateway Conference on September 10, 2020GlobeNewsWire • 09/03/20
Plus Therapeutics, Inc.(PSTV) CEO Marc Hedrick on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/11/20
Plus Therapeutics To Report Second Quarter Fiscal Year 2020 Financial Results And Corporate Update on August 10, 2020GlobeNewsWire • 08/03/20
Plus Therapeutics Completes Fifth Dose Escalation Cohort of the ReSPECT™ Glioblastoma Clinical Trial and Expands Trial SitesGlobeNewsWire • 07/28/20
Plus Therapeutics to Present at the YAFO Access China Partnering Conference on July 30, 2020GlobeNewsWire • 07/23/20
Plus Therapeutics, Inc. (PSTV) CEO Marc Hedrick on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/15/20
Plus Therapeutics Announces Closing of Agreement To License Novel Oncology PlatformGlobeNewsWire • 05/11/20
Plus Therapeutics Donates Personal Protective Equipment to Scripps Health to Confront COVID-19 PandemicGlobeNewsWire • 04/06/20
Plus Therapeutics Announces Dr. Gregory Stein as Head of Clinical DevelopmentGlobeNewsWire • 04/01/20
Plus Therapeutics, Inc. (PSTV) CEO Dr. Marc Hedrick on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/31/20
Plus Therapeutics Shareholder Update: Transition Achieved in 2019; Poised for Expansion in 2020GlobeNewsWire • 01/06/20